Paediatric Hepatobiliary
Maximizing Kasai portoenterostomy in the treatment of biliary atresia: Medical and surgical options
Mark Davenport, Andrew Grieve
Abstract
Biliary atresia (BA) remains one of the most challenging conditions in paediatric surgery. It has several possible causes, resulting in a range of different clinical scenarios. The current therapeutic approach is almost entirely surgical with an initial attempt to restore bile flow and preserve the native liver using a Kasai-type portoenterostomy. Liver transplantation (cadaveric or living donor) is usually reserved for failure or for infants presenting late with end-stage cirrhosis. The role of adjuvant medical therapy is unclear and evidence of benefit is lacking. Nonetheless, the use of post-operative steroids, prophylactic antibiotics and choleretic agents such as ursodeoxycholic acid is common. Ideally, the entire pathway should be complementary and seamless with few infants dying of end-stage liver disease or uncorrectable associated congenital malformations. Experience from high-volume centres suggests that clearance of jaundice can be achieved in 50 - 60% of infants with 10-year native liver and real survival rates of 45% and 90%, respectively.
Authors' affiliations
Mark Davenport, Department of Paediatric Surgery at Kings College Hospital, London
Andrew Grieve, Department of Paediatric Surgery, University of the Witwatersrand, Johannesburg
Keywords
Biliary atresia; portoenterostomy
Article History
Date submitted: 2012-07-08
Date published: 2012-09-10
Article Views
Abstract views: 3461
Full text views: 9528
Comments on this article
*Read our policy for posting comments
here
Comments on this article
*Read our policy for posting comments here